Edition:
United States

United Therapeutics Corp (UTHR.O)

UTHR.O on Nasdaq

149.04USD
10:29am EST
Change (% chg)

$1.10 (+0.74%)
Prev Close
$147.94
Open
$148.61
Day's High
$150.35
Day's Low
$147.98
Volume
110,939
Avg. Vol
592,788
52-wk High
$153.07
52-wk Low
$97.52

UTHR.O

Chart for UTHR.O

About

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. Its therapeutic products and product candidates include Prostacyclin Analogues, Phosphodiesterase Type 5 (PDE-5) Inhibitor and... (more)

Overall

Beta: 1.40
Market Cap(Mil.): $6,274.95
Shares Outstanding(Mil.): 42.42
Dividend: --
Yield (%): --

Financials

  UTHR.O Industry Sector
P/E (TTM): 9.97 45.86 30.46
EPS (TTM): 14.84 -- --
ROI: 39.82 -1.27 14.82
ROE: 42.54 -1.00 16.24

BRIEF-United Therapeutics reports Q3 EPS $3.50

* United therapeutics corporation reports third quarter 2016 financial results

Oct 27 2016

Competitors

Earnings vs. Estimates